This study is looking at a new urine test called Cxbladder Triage Plus. This test uses special markers in your urine (RNA and DNA biomarkers) to help doctors decide if you might have bladder cancer. Many people who have invisible blood in their urine (microhematuria) need a procedure called a cystoscopy, where a small camera looks inside the bladder. This can be uncomfortable. The study wants to see if using the Cxbladder Triage Plus test can reduce the number of cystoscopies performed on patients with invisible blood in their urine. You may be able to join if you are an adult between 18 and 88 years old, and have been referred to a urologist for invisible blood in your urine. The study aims to enroll 1000 participants.

Study design

This is an interventional study, meaning participants will receive a specific intervention (the Cxbladder Triage Plus test). It plans to enroll 1000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure the rate of cystoscopies at 3 months after the decision to perform or not perform a cystoscopy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.